DOH informs stakeholders on the change in schedule of the Batch 2 AMS Blended Learning Program for Hospitals
Updated Suggested Retail Price (SRPs) for Emergency Essential Medicines due to the Coronavirus Disease 2019 (COVID-19) Health Event as of April 22, 2022
DOH adds Molnupiravir (400 mg) in the Updated SRP List
ASEAN Member States Virtually Assemble in the recent Drug Price Transparency Workshop
The Association of Southeast Asian Nations (ASEAN) Member States, comprising Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, and Vietnam, convened in a two-day online workshop to ensure fair prices and effective financing of medicines and health technologies with the aim to fortify health systems and to achieve wider Universal Health Coverage on April 6-7, 2022.
DOH’s 15th Patient Forum Highlights COVID Response, Accessibility of Health Commodities
The Department of Health (DOH) on March 30, 2022 convened patient groups and civil society organizations (CSOs) to discuss updates on the national government’s COVID-19 response, vaccination program rollout, and the ongoing initiatives to provide Filipinos better access to pharmaceutical commodities and healthcare services during the virtual 15th Policy Dialogue on Universal Health Care (UHC) and Access to Medicines with theme “Gamot Para sa Lahat, Siguruhing Sasapat”.
DOH Announces Full Implementation of Drug Price Caps with Executive Order No. 155
The Department of Health (DOH) announces the full implementation of drug price caps starting March 23, 2022 through Executive Order (EO) No. 155 signed by President Rodrigo Duterte. This brings the total number of drugs with maximum drug retail price to 121 molecules or 204 drug formulas, following the first round of price regulation implemented in June 2020 with the signing of EO No. 104 which covered 87 molecules.